Peripheral Arterial Disease
"Peripheral Arterial Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Descriptor ID |
D058729
|
| MeSH Number(s) |
C14.907.137.126.307.500 C14.907.617.671
|
| Concept/Terms |
Peripheral Arterial Disease- Peripheral Arterial Disease
- Arterial Disease, Peripheral
- Arterial Diseases, Peripheral
- Disease, Peripheral Arterial
- Diseases, Peripheral Arterial
- Peripheral Arterial Diseases
- Peripheral Artery Disease
- Artery Disease, Peripheral
- Artery Diseases, Peripheral
- Disease, Peripheral Artery
- Diseases, Peripheral Artery
- Peripheral Artery Diseases
|
Below are MeSH descriptors whose meaning is more general than "Peripheral Arterial Disease".
Below are MeSH descriptors whose meaning is more specific than "Peripheral Arterial Disease".
This graph shows the total number of publications written about "Peripheral Arterial Disease" by people in this website by year, and whether "Peripheral Arterial Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 6 | 0 | 6 |
| 2012 | 3 | 0 | 3 |
| 2013 | 4 | 0 | 4 |
| 2014 | 5 | 0 | 5 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 5 | 1 | 6 |
| 2018 | 5 | 1 | 6 |
| 2019 | 8 | 0 | 8 |
| 2020 | 10 | 0 | 10 |
| 2021 | 8 | 0 | 8 |
| 2022 | 4 | 0 | 4 |
| 2023 | 7 | 0 | 7 |
| 2024 | 7 | 2 | 9 |
| 2025 | 4 | 0 | 4 |
| 2026 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peripheral Arterial Disease" by people in Profiles.
-
Association of elective peripheral vascular intervention with outcomes among patients with peripheral arterial disease and intermittent claudication. J Vasc Surg. 2026 Oct; 84(4):1013-1024.e16.
-
Risk Scores for the Loss of Secondary Patency and Major Amputation After Successful Thrombectomy of an Infra-inguinal Arterial Bypass. Ann Vasc Surg. 2026 Oct; 131:183-205.
-
End-to-end proximal anastomosis is the sole modifiable variable in risk score for loss of patency of aortobifemoral artery bypass after index operative hospitalization. J Vasc Surg. 2026 Oct; 84(4):888-903.e1.
-
A systematic review and meta-analysis of elevated lipoprotein(a) and adverse limb outcomes in peripheral artery disease after revascularization. J Vasc Surg. 2026 Sep; 84(3):671-685.e5.
-
Community-based recruitment with ankle brachial index testing to identify peripheral artery disease participants for randomized clinical trials. Am Heart J. 2026 Oct; 300:107450.
-
Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical Trial. JAMA. 2026 Feb 03; 335(5):407-415.
-
Duration of Supervised Exercise Necessary for Meaningful Improvement in Peripheral Artery Disease. J Am Heart Assoc. 2025 09 16; 14(18):e040058.
-
Risk scores for myocardial infarction and major adverse cardiac event following major amputation for limb ischemia with internal VQI validation. J Vasc Surg. 2025 12; 82(6):2210-2223.e9.
-
Risk factors contributing to 30-day and 1-year mortality event scores following major lower extremity amputation for limb ischemia. J Vasc Surg. 2025 07; 82(1):216-228.e1.
-
Hepatocyte growth factor for walking performance in peripheral artery disease. J Vasc Surg. 2025 06; 81(6):1467-1478.e1.